BeOne Medicines (ONC) Income from Non-Controlling Interests (2017 - 2020)

BeOne Medicines (ONC) has 4 years of Income from Non-Controlling Interests data on file, last reported at $96000.0 in Q4 2020.

• On a quarterly basis, Income from Non-Controlling Interests fell 42.17% year-over-year to $96000.0 in Q4 2020; TTM through Sep 2021 was $96000.0, a 102.71% increase from a year earlier, with the FY2020 full-year figure at -$3.6 million, down 85.49% from the prior year.
• Income from Non-Controlling Interests for Q4 2020 stood at $96000.0, up from -$1.4 million in the prior quarter.
• Over the last five years, Income from Non-Controlling Interests for ONC reached as high as $1.5 million in Q4 2018 and fell as low as -$1.4 million in Q3 2020.
• Historically, Income from Non-Controlling Interests has averaged -$401666.7 across 4 years, with a median of -$429000.0 in 2019.
• On a YoY basis, Income from Non-Controlling Interests climbed as much as 3493.02% in 2018 and fell as far as 513.33% in 2018.
• Year by year, Income from Non-Controlling Interests stood at $43000.0 in 2017, then surged by 3493.02% to $1.5 million in 2018, then tumbled by 89.26% to $166000.0 in 2019, then slumped by 42.17% to $96000.0 in 2020.
• Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $96000.0 in Q4 2020, -$1.4 million in Q3 2020, and -$1.1 million in Q2 2020.